header advert
Results 1 - 3 of 3
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXI | Pages 75 - 75
1 May 2012
H. S J.J. D A. U B. B
Full Access

Objective

To assess patterns of recurrence in patients with Dupuytren's disease after surgery for proximal interphalangeal joint (PIPJ) deformity.

Methods

81 patients (94 fingers) with Duputyren's contracture of the proximal interphalangeal joint underwent surgery to have either a ‘firebreak’ skin graft (46 fingers) or a fasciectomy (48 fingers). They were reviewed after three weeks, six weeks, 6, 12, 24 and 36 months to note the range of movement and recurrence. Both groups were similar with regard to age, gender and factors considered to influence the outcome such as bilateral disease, family history, and the presence of diabetes, smoking and alcohol intake.


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXI | Pages 173 - 173
1 May 2012
E. S E. L B. B
Full Access

Background

Oxford joint scores are increasingly being used in evaluating outcomes following orthopaedic surgery. These patient-reported outcome measures (PROM) have been well validated, but only before and after surgical intervention. We postulated that the scores would deteriorate in the normal population with age.

Methods

Members of the public accompanying patients to out-patients and the emergency department in our hospitals were asked to complete an Oxford score questionnaire having ascertained that they had no previous problem with that joint. Exclusions included other multiple joint pathologies and known connective tissue disorders. Power analysis advocated 40 subjects per decade per joint for significance at the 80% mark. 993 subjects between 20 and 80 years of age completed the forms. There were more females than males. The scores were analysed using STATA 8 software. Non-parametric tests of variance, regression analysis, and ANOVA were used. The data were analysed by decades.


Orthopaedic Proceedings
Vol. 84-B, Issue SUPP_III | Pages 292 - 292
1 Nov 2002
C. DT E. B A. F M. N B. B
Full Access

Malignant hyperthermia (MH) is a pharmacogenetic disorder, potentially lethal, due to the exposure to anesthetic drugs that triggers, a high increase of corporal temperature, progressive muscular stiffness, severe rabdomiolisis and death due to cardiac dysfunction. Many research works relate Malignant Hyperthermia to muscular illnesses or to the King Syndrome. Through this study we present the incidence of MH in patients with congenital vertebrae malformations. (CVM)

The objective is to establish the incidence of the MH in patients who were operated on CVM and to alert about this association.

1029 patients with CVM were treated between 1972 and 2000. 390 with congenital vertebrae malformation were operated on. 3 patients (0.76%) (1 girl and 2 boys) developed MH while they underwent surgical treatment for the CVM. 1 patient presented an isolated congenital vertebrae malformation. 1 patient presented King Syndrome and the other presented Robert Syndrome. Only 1 elevated amount of preoperative CPK was found (the are no reports on the others).

No muscular biopsy was done to test sensitivity. Two of them were biopsied for a post episode study. At the surgical moment, any patients reported personal or familiar antecedents of MH. No deaths were reported, although it is considered as a potentially lethal disorder.

We found no reports in the literature in this subject. Most of the bibliographic data belonged to anesthesiologists or geneticists. Our approach as spine surgeons leaded us to the detailed analysis of this studies and the 0.76% (3 out of 390) incidence suggested us to have an alert attitude when facing patients with surgical MVC and take the necessary precautions.